Search
HIV Infections Clinical Trials
A listing of 70 HIV Infections clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 70
There are currently 70 active clinical trials seeking participants for HIV Infections research studies. The states with the highest number of trials for HIV Infections participants are California, New York, Florida and Texas.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Recruiting
People living with human immunodeficiency virus (PLWH) have an estimated 1.6-6.0 times increased risk of developing oropharyngeal cancer (OPC) compared with individuals in the general population. 70% of OPCs are caused by human papillomavirus (HPV), and PLWH also have an increased prevalence of oral HPV infection. Disparities by race/ethnicity also include a later stage of diagnosis and less frequent cancer-directed treatment for members of ethnic minority groups. There is little known regarding... Read More
Gender:
ALL
Ages:
35 years and above
Trial Updated:
07/29/2025
Locations: University of California, San Francisco, San Francisco, California
Conditions: HPV Infection, HIV Infections, HPV-Related Malignancy
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
Recruiting
This pilot feasibility study represents part 3 of a larger R61 study, where the investigators will follow a cohort about their experiences with human immunodeficiency virus (HIV) testing.
This project aims to assess the effectiveness of an intervention at two jail sites in the Boston area: South Bay House of Corrections and Nashua Street Jail implemented in January of 2025 that is aimed at improving HIV testing practices and HIV treatment in those carceral facilities. This implementation was de... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/28/2025
Locations: South Bay House of Corrections, Boston, Massachusetts
Conditions: HIV Infections, Opioid Use Disorder
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
Recruiting
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be co... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: South End Community Health Center, Boston, Massachusetts +1 locations
Conditions: HIV Infections
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
Recruiting
The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/21/2025
Locations: University of Miami, Miami, Florida
Conditions: HIV Infections
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
Recruiting
This study will assess how effective, safe, and long-lasting a long-acting antiretroviral therapy (ART) using CAB LA + RPV LA is for people with HIV who still have detectable virus levels despite being on oral ART. The study will also consider feedback from patients on their experience with this treatment.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
07/16/2025
Locations: GSK Investigational Site, Birmingham, Alabama +59 locations
Conditions: HIV Infections
A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV
Recruiting
This study evaluates the safety, tolerability, and pharmacokinetics (PK) of a single dose administration of VH4527079 by subcutaneous (SC) injection or by intravenous (IV) infusion in healthy adult participants, multiple dose administration by IV infusion in healthy adult participants and in Persons with HIV (PWH) and co-administration with rHuPH20 via SC infusion in healthy adult participants.
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/16/2025
Locations: GSK Investigational Site, Las Vegas, Nevada +1 locations
Conditions: HIV Infections
Skeletal Muscle Energetics and Fatiguability in Older Individuals
Recruiting
The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.
Gender:
ALL
Ages:
Between 60 years and 90 years
Trial Updated:
07/09/2025
Locations: Johns Hopkins Hospital, Baltimore, Maryland
Conditions: HIV, HIV Infections
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
Recruiting
The investigator will study the origin of fungal translocation in HIV, its relationship to the mycobiome, and its relationship to lung function and inflammation. Supported by the preliminary data and published studies, this project is based on the premise that circulating BDG derived from microbial translocation stimulates inflammation and worsens lung function in PWH.
Chronic obstructive pulmonary disease (COPD) is a significant public health problem with few therapies that modify disease traj... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
07/09/2025
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania
Conditions: HIV Infections, Inflammation, COPD
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Recruiting
SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/02/2025
Locations: San Francisco General Hospital, San Francisco, California
Conditions: HIV Infections
CAR-T Cells for HIV Infection
Recruiting
This is a limited-center, open-label dose escalating phase I/IIa study of autologous T cells expressing LVgp120duoCAR molecules in people with HIV infection. It will follow a 3+3 design. Dose escalation decisions will be made when a minimum of three participants have completed the safety-evaluation period (45 days) at a given dose level. Cohort 1 will undergo infusion of a single low-dose regimen of LVgp120duoCAR-T cells. Cohort 2 will undergo non-ablative conditioning with cyclophosphamide, fol... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/01/2025
Locations: University of California, Davis, Sacramento, California +1 locations
Conditions: HIV Infections
Community-based Education, Navigation, and Support Intervention for Military Veterans
Recruiting
Military veterans in the U.S. represent one of the populations most disproportionately impacted by the current opioid crisis. Veterans who use opioids and are not connected to the VA healthcare system have high rates of homelessness and experience higher prevalence of comorbid substance use disorder and mental health diagnoses than their "service-connected" counterparts. Due to these vulnerabilities and the observed barriers to testing and treatment among veterans-especially substance- and menta... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/26/2025
Locations: New York University, New York, New York
Conditions: Overdose, Opioid Use Disorder, HIV Infections
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Recruiting
This is an open-label, dose-escalation study to investigate the safety, tolerability and pharmacokinetics (PK) of single subcutaneous (SC) administration of long acting (LA) Cabotegravir (CAB) 200 milligrams per milliliter (mg/mL) with Recombinant Human Hyaluronidase PH20 (rHuPH20) (Part A), a single-dose or repeat-dose SC or intramuscular (IM) administration of LA CAB (greater than or equal to) \>=400 mg/mL (Part C), single-dose IM administration of LA CAB Formulation I (Part C Cohort C8) and L... Read More
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
06/25/2025
Locations: GSK Investigational Site, Orlando, Florida +2 locations
Conditions: HIV Infections
1 - 12 of 70